Cd161-clec2d
Nk prostate cell inhibits mediated overexpression interaction cells killing cancer through (pdf) overexpression of llt1 (ocil, clec2d) on prostate cancer cells Nk lectin receptor ligand receptors killer ligands encoded frontiersin mhc fimmu nkc immunology frontiers
Frontiers | CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High
Cd4 cd8 cells positive double helper cancer high urological frontiersin polarization cancers favor enriched figure representative dp Cd161 basis molecular recognition binding Handle redirect
Cd11b cd103 cells dendritic mucosal
Figure 1 from overexpression of llt1 (ocil, clec2d) on prostate cancerCd63 antibody immunofluorescence fitc ma1 mem monoclonal icc Cd103+cd11b+ mucosal classical dendritic cells initiate long-termCells cd8 memory cytotoxic mait frontiersin potential therapeutic high fimmu.
Cd63 antibody, fitc (ma1-19602)Prostate cancer nk interaction Cd58 frontiersin immunobiology glance fimmuMolecular basis for llt1 protein recognition by human cd161 protein.
Handle Redirect
CD63 Antibody, FITC (MA1-19602)
CD103+CD11b+ mucosal classical dendritic cells initiate long-term
Frontiers | Double Positive CD4+CD8+ T Cells Are Enriched in Urological
Frontiers | CD58 Immunobiology at a Glance
Figure 1 from Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer
Molecular Basis for LLT1 Protein Recognition by Human CD161 Protein
(PDF) Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells